Atlas FDA

INTERSTIM THERAPY

FDA premarket approval P080025/S031 · decided 2012-06-05

Approval details

PMA number
P080025
Supplement
S031
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2012-05-07
Decision date
2012-06-05
Days to decision
29 days
Decision code
OK30
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
ADDITION OF AN ALTERNATE QUALIFIED SUB-TIER SUPPLIER FOR COMPONENTS USED IN PATIENT PROGRAMMERS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23